TRANSLATIONAL AND CLINICAL MEDICINE - Georgian Medical Journal

Abstract

Ischemic heart disease (IHD) has steadily occupied the  leading position among cardio-vascular diseases (CVD) in terms of patient referrals, disability and mortality in economically developed countries. According to statistics, 17 million people die from CVD every year and among them 7 million deaths are caused by IHD. It is expected that the number of deaths from ischemic disease will be even increased overtime. 

The major problem represents poly-morbidity ( the combination of various diseases with one patient). Poly-morbidity is mainly characteristic to the patients of elderly age group, who are over 60 years old. The course, therapy and prevention of the disease mainly depends on the concomitant diseases, against the bakground of which the IHD has developed

IHD and chronic obstructive pulmonary disease (COPD) very often represent the comorbid  diseases. According to the researches of various authors, COPD has been identified to be concomitant with IHD in 62% cases of  patients with COPD.

Nowadays, in terms of mortality COPD occupies the fourth place worldwide  with the possible  perspective of progression in respect of its incidence as well as mortality in the nearest decade. According to World Health Organization (WHO), in 2020  COPD was ranked 5th for the economic damage inflicted  by the diseases at the global scale.

In the epidemiologic researches on morbidity and mortality the due assessment of the extent of damage caused by COPD is not frequently conducted, because it is not diagnosed prior to the onset of severe clinical stage of the disease.  

Social factors for  the prevalence of CVD and COPD represent  the violation of urbanization and ecological balance of the population. These processes are accompanied by the sedentary lifestyle, smoking, malnutrition, which, as a rule, are risk-factors for COPD and CVD.